GENEVA, Dec. 15 -- INNOLAKE BIOPHARMA (HANGZHOU) CO., LTD. (Room 301, Building 24, Yinhai Sci-Tech Innovation Center, Xiasha Street, Qiantang DistrictHangzhou, Zhejiang 310018), 英诺湖医药（杭州）有限公司 (中国浙江省杭州市钱塘新区下沙街道银海科创中心24幢301室) filed a patent application (PCT/CN2025/099364) for "ANTI-DLL3 AND B7-H3 BISPECIFIC ANTIBODY-DRUG CONJUGATE" on Jun 05, 2025. With publication no. WO/2025/252164, the details related to the patent application was published on Dec 11, 2025.
Notably, the patent applica...